Home Applications 021226 Application 021226
Type NDA
Sponsor ABBVIE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 KALETRA LOPINAVIR; RITONAVIR CAPSULE;ORAL 133.3MG;33.3MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021226-001 KALETRA LOPINAVIR; RITONAVIR 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N021226-001 KALETRA 133.3MG;33.3MG CAPSULE / ORAL 2000-09-15 f41ea6bd6efb…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021226-001 7141593 2020-05-22 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021226-001 7432294 2020-05-22 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021226-001 7141593*PED 2020-11-22 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021226-001 7432294*PED 2020-11-22 Pediatric extension 74a2ff9319b5…2019-12-14 00:12 UTC 2019-12 N021226-001 7141593 2020-05-22 Drug product 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021226-001 7432294 2020-05-22 Drug product 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021226-001 7141593*PED 2020-11-22 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021226-001 7432294*PED 2020-11-22 Pediatric extension 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021226-001 7141593 2020-05-22 Drug product b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021226-001 7432294 2020-05-22 Drug product b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021226-001 7141593*PED 2020-11-22 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021226-001 7432294*PED 2020-11-22 Pediatric extension b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021226-001 7141593 2020-05-22 Drug product ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021226-001 7432294 2020-05-22 Drug product ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021226-001 7141593*PED 2020-11-22 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021226-001 7432294*PED 2020-11-22 Pediatric extension ea99ee380514…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Kaletra LOPINAVIR AND RITONAVIR AbbVie Inc. 8290add3-4449-4e58-6c97-8fe1eec972e3 2026-07-23 Warnings, Adverse reactions Name fallback brand name: Kaletra
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.